EVALUATION OF INFLAMMATION-RELATED HEMOGRAM PARAMETERS AS A USEFUL MARKER IN PAPILLARY THYROID CARCINOMA

Abstract

Objective Inflammation-related hemogram parameters have recently started to be defined as a useful marker in cancer patients. In this study, we aimed to comparison of hemogram parameters in papillary thyroid cancer (PTC) patients, well differentiated thyroid tumor of uncertain malignant potential (WDT-UMP) and follicular adenoma (FA). Material and Method The 287 patients’ data were analyzed in study. Study subjects were divided into 5 different groups. 1st group: control, 2nd group: FA, 3rd group: WDT-UMP, 4th group: non-metastatic PTC, 5th group: metastatic PTC. We evaluated the preoperative blood tests. Results The average age was 50 (37-59). The mean TSH value was 1.2 (0.5-2.2) μIU/mL. The mean size of the lesion detected in the total thyroidectomy material was 1.7 (1.0-3.0) cm. White blood cells (WBC), neutrophils and lymphocytes were lower in 3rd group than 4th group (p<0.05). NLR was found to be similar in all groups with the control group (p=0.173). MPV was found to be statistically higher in the control patients (p=0.000). MPV was significantly higher in 2nd group compared to 3rd group and 4th group (p=0.001, p=0.016; respectively). RDW was significantly lower in the control group compared to all other groups (p=0.000). There was no correlation between tumor size and hemogram parameters. Conclusion In patients followed up for thyroid nodules, low MPV should raise a suspicion in terms of possible malignancy. Increased RDW may be useful in predicting thyroid nodule development. These easily accessible, cost-effective markers may support other diagnostic methods to distinguish malignant from benign nodules.

Keywords

• papillary thyroid cancer
• WDT-UMP
• follicular adenoma
• MPV
• RDW

Project Number

YOK

PAPİLLER TİROİD KARSİNOMUNDA YARARLI BİR BELİRTEÇ OLARAK İNFLAMASYONLA İLİŞKİLİ HEMOGRAM PARAMETRELERİNİN DEĞERLENDİRİLMESİ

Abstract

Amaç İnflamasyona bağlı hemogram parametreleri son zamanlarda kanser hastalarında faydalı bir belirteç olarak tanımlanmaya başlamıştır. Bu çalışmada, papiller tiroid kanserli (PTC), malignite potansiyeli belirsiz iyi diferansiye tiroid tümörü ve foliküler adenomlu (FA) hastalarda hemogram parametrelerinin karşılaştırılması amaçlandı. Gereç ve Yöntem Çalışmada 287 hastanın verileri analiz edildi. Çalışma popülasyonu 5 farklı gruba ayrıldı. 1. Grup: kontrol, 2. grup: FA, 3. grup: WDT-UMP, 4. grup: metastatik olmayan PTC, 5. grup: metastatik PTC. Ameliyat öncesi yapılan kan testlerini değerlendirdik. Bulgular Ortalama yaş 50 (37-59) idi. Ortalama TSH değeri 1.2 (0.5-2.2) μIU/mL idi. Total tiroidektomi materyalinde saptanan lezyonun ortalama boyutu 1.7 (1.0-3.0) cm idi. Grup 3'te beyaz kan hücreleri (WBC), nötrofiller ve lenfositler grup 4'e göre daha düşüktü (p<0.05). NLR, kontrol grubu ile tüm gruplarda benzer bulundu (p=0.173). Kontrol hastalarında MPV istatistiksel olarak daha yüksek oranda bulundu (p=0.000). MPV 2. grupta, 3. grup ve 4. grupa göre anlamlı derecede yüksekti (sırasıyla p=0.001, p=0. 016;). RDW, kontrol grubunda diğer gruplara göre anlamlı derecede düşüktü (p=0.000). Tümör boyutu ile hemogram parametreleri arasında korelasyon yoktu. Sonuç Tiroid nodülü nedeniyle takip edilen hastalarda düşük MPV olası malignite açısından şüphe uyandırmalıdır. Artmış RDW, tiroid nodülü gelişimini öngörmede faydalı olabilir. Bu kolay erişilebilir, uygun maliyetli belirteçler, malign nodülleri benign nodüllerden ayırt etmek için diğer tanı yöntemlerini destekleyebilir.

Keywords

• papiller tiroid kanseri
• WDT-UMP
• foliküler adenom
• MPV
• RDW

Supporting Institution

yok

Project Number

YOK

Thanks

YOK

References

1. 1. Hsu DS, Kim MK, Balakumaran BS, et al. Immune signatures predict prognosis in localized cancer. Cancer Investigation. 2010;28(7):765-73.
2. 2. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Vol. 357, Lancet. Elsevier Limited; 2001. p. 539–45.
3. 3. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-7.
4. 4. Ari A, Gunver F. Comparison of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in patients with thyroiditis and papillary tumors. Journal of International Medical Research. 2019;47(5):2077-83.
5. 5. Yokota M, Katoh H, Nishimiya H, et al. Lymphocyte-monocyte ratio significantly predicts recurrence in papillary thyroid cancer. Journal of Surgical Research. 2020;246:535-43.
6. 6. Çölkesen F. Pankreas kanserli hastalarda hematolojik parametrelerin (mean platelet volume, nötrofil/lenfosit oranı, trombosit/ lenfosit oranı, eozinofil ve lenfosit sayısı) prognoz - tedavi takibinde kullanılabilirliklerinin araştırılması. Selçuk Üniversitesi, Yayımlanmış Uzm tezi, Kony. 2015.
7. 7. Lang BH, Ng CP, Au KB, et al. Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma?. World journal of surgery. 2014:2605-12.
8. 8. Lian L, Xia YY, Zhou C, et al. Mean platelet volume predicts chemotherapy response and prognosis in patients with unresectable gastric cancer. Oncology letters. 2015;10(6):3419-24.

9. 9. Hussein O, Abdelwahab K, Hamdy O, et al. Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area. Journal of the Egyptian National Cancer Institute. 2020;32(1):1-4.
10. 10. Li MM, Yue CX, Fu S, et al. Platelet volume is reduced in metastasing breast cancer: Blood profiles reveal significant shifts. Cancer Management and Research. 2019;11:9067.
11. 11. Lai X, Xia Y, Zhang B, et al. A meta-analysis of Hashimoto’s thyroiditis and papillary thyroid carcinoma risk. Oncotarget. 2017;8(37):62414.
12. 12. Wang X, Cui MM, Xu Y, et al. Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer. Oncotarget. 2017;8(40):68115.
13. 13. Feng J, Wang Y, Shan G, et al. Clinical and prognostic value of neutrophil-lymphocyte ratio for patients with thyroid cancer: A meta-analysis. Medicine. 2020;99(20).
14. 14. Al-Kindi SG, Refaat M, Jayyousi A, et al. Red cell distribution width is associated with all-cause and cardiovascular mortality in patients with diabetes. BioMed research international. 2017;2017.
15. 15. Sit M, Aktas G, Ozer B, et al. Mean platelet volume: an overlooked herald of malignant thyroid nodules. Acta Clinica Croatica. 2019;58(3):417.
16. 16. Montagnana M, Danese E. Red cell distribution width and cancer. Annals of translational medicine. 2016;4(20).
17. 17. Paliogiannis P, Scognamillo F, Bellomo M, e al. Neutrophil to lymphocyte ratio as a predictor of thyroid papillary carcinoma. Acta Med Mediterr. 2015;31:371-5.
18. 18. Hu L, Li M, Ding Y, et al. Prognostic value of RDW in cancers: a systematic review and meta-analysis. Oncotarget. 2017;8(9):16027.
19. 19. Liu CL, Lee JJ, Liu TP, et al. Blood neutrophil‐to‐lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer. Journal of surgical oncology. 2013;107(5):493-7.
20. 20. Aktas G, Sit M, Karagoz I, et al. Could red cell distribution width be a marker of thyroid cancer. J Coll Physicians Surg Pak. 2017;27(9):556-8.
21. 21. Liu JF, Ba L, Lv H, et al. Association between neutrophil-to-lymphocyte ratio and differentiated thyroid cancer: a meta-analysis. Scientific reports. 2016;6(1):1-7.
22. 22. Sevinc B, Karahan O, Ay S, et al. Red cell distribution width as a marker of thyroid papillary carcinoma. Translational Surgery. 2016;1(2):41-.
23. 23. Pyo JS, Sohn JH, Kang G. Diagnostic and prognostic roles of the mean platelet volume in malignant tumors: a systematic review and meta-analysis. Platelets. 2016;27(8):722-8.
24. 24. Kayilioglu SI, Dinc T, Sozen I, et al. Thyroid nodules with atypia or follicular lesions of undetermined significance (AUS/FLUS): analysis of variables associated with outcome. Asian Pacific Journal of Cancer Prevention. 2015;15(23):10307-11.
25. 25. Ozmen HK, Askin S, Simsek E, et al. Mean Platelet Volume and Red Cell Distribution Width in Differentiated Thyroid Cancer Patients. Open Medicine Journal. 2019;6(1).
26. 26. Dincel O, Bayraktar C. Evaluation of platelet indices as a useful marker in papillary thyroid carcinoma. Bratislava Med J. 2017;118(3):153-5.
27. 27. Yu YJ, Li N, Yun ZY, et al. Preoperative mean platelet volume and platelet distribution associated with thyroid cancer. Neoplasma. 2017;64(4):594-8.
28. 28. Li N, Fu S, Cui MM, et al. Platelet distribution width and serum albumin levels for discrimination of thyroid cancer from benign thyroid nodules. Asian Pacific Journal of Cancer Prevention: APJCP. 2017;18(7):1773.
29. 29. Yagyu T, Saito H, Sakamoto T, et al. Decreased mean platelet volume predicts poor prognosis in patients with pancreatic cancer. BMC surgery. 2021;21(1):1-8.
30. 30. Delago D, Knittelfelder O, Jakse G, et al. The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy. Radiation Oncology. 2020;15(1):1-2.